SYMPOSIA
SYMPOSIA
SYMPOSIA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Poster Presentations<br />
[PP-061] Ref. No: 233<br />
Evaluation of cognitive functions in euthymic bipolar patients using<br />
mono- and multi- drug treatments<br />
Birgül Elbozan Cumurcu 1 , Rıfat Karlıdağ 1 , Şükrü Kartalcı 1 , Işıl Göğcegöz Gül 1 , Süleyman Demir 2 , Bahar Yeşil 1<br />
1 Inonu University Medical Faculty, Turgut Ozal Medical Center, Department of Psychiatry, Malatya, Turkey<br />
2 Gaziosmanpasa University School of Medicine, Department of Psychiartry, Tokat, Turkey<br />
E-mail: baharyesilege@hotmail.com<br />
Objective: Some studies on patients suffering from bipolar disorder show that in active and remission periods of the disorder there are<br />
cognitive insufficiencies (1,2,3). The causes of cognitive insuffuciencies in bipolar disorder is not understood yet. We anticipate that multidrug<br />
usage has more adverse effects on cognitive functions than mono- drug usage and our aim in this study was to investigate effects of<br />
drugs used in treatment of bipolar disorder on cognitive functions. In this study we evaluated the cognitive functions of bipolar patients<br />
who were in their euthymic period taking mono- and multi-drug regimens and compared them with a healthy control group.<br />
Methods: Eighty bipolar I and II patients diagnosed based on the DSM-IV criteria and 80 healthy controls were included in the study and<br />
two groups matched according to age, sex, and education aspects. The patients and controls gave written informed consent to participate<br />
in the study. The necessary approval and ethic committee reviews and permits were obtained prior to the study. The patients were<br />
evaluated using a psychiatric interview, the Young Mania Scale and the Hamilton Depression Rating Scale. A large neurocognitive battery<br />
(Wechsler Memory Scale-Revised, Stroop,Verbal Memory Processes Scale) was used for neurocognitive assessment.<br />
Results: In most cognitive tests the results of the patient group were worse than the control group. The Verbal Memory Processes<br />
Scale-learning scores and long term memory scores were higher in the patients on a mono-drug regimen. All other tests did not show<br />
significant differences.<br />
Conclusions: Our study showed that the cognitive function of bipolar patients had deficiencies not only in active periods of bipolar<br />
disorder but also in remission periods, like previous studies (4,5,6).<br />
The Verbal Memory Processes Scale learning scores and long term memory scores showed better results in patients using a mono-drug<br />
compared to the ones on a multi-drug regimen. Other tests did not show significant differences. Future studies with larger number of<br />
patients may show different results. Also other studies to investigate the effects of each drug group on cognitive functions in bipolar<br />
patients are needed.<br />
Key words: Bipolar disorder, cognitive functions, euthymia<br />
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S158<br />
[PP-062] Ref. No: 247<br />
Adult ADHD symptoms in cannabis dependence and the importance of<br />
comorbidity in Adult ADHD<br />
Umut Mert Aksoy, Şennur Günay Aksoy, Fulya Maner<br />
Bakirkoy Research And Teaching Hospital For Neuropsychiatry, İstanbul, Turkey<br />
E-mail: drumutmertaksoy@gmail.com<br />
Background: Adult Attention Deficit Hyperactivity Disoeder (A-ADHD) is one of the most important neuropsychiatric disorders originating<br />
in childhood. According to the last epidemiological studies, ADHD can be persistent into adulthood. Sixty percent of childhood ADHD<br />
cases present with at one or more symptoms in adulthood (Biedermann 2000, Wilens 2006). A prevalance rate of 4.4% of adults has been<br />
reported for ADHD (Fayyad 2007, Kessler 2006).<br />
Comorbidity with alcohol and substance use disorders in A-ADHD is also common and reported as 50%, which is 2-3 times more common<br />
than in the normal population (15%) (Katusic 2005). A-ADHD is reported to be an independent risk factor for substance abuse. Comorbid<br />
substance use disorders have been observed at rates of 9-30& (Wilens 2006).<br />
Individuals with substance use dişorders comorbid with A-ADHD do not differ in substance preference from individuals without A-ADHD<br />
comorbidity. Cannabis is the most abused substance.<br />
Objective: We aimed to demonstrate the existence and intensity of Adult ADHD symptoms in cannabis dependent individiuals and<br />
discuss the importance of comorbid A-ADHD.<br />
Methods: Seventy patients participated and gave informed consent. The participants were selected from patients who underwent<br />
S158 Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org